FierceBiotechOriginal article
{"a":[{"_":"FDA launches pilot program to speed up sluggish phase 1 trials","$":{"href":"/biotech/fda-launches-pilot-program-speed-sluggish-phase-1-trials","hreflang":"en"}}]}
RegulatoryPositive
AI Analysis
Summary
The FDA launched a pilot program to expedite the investigational new drug (IND) application process for phase 1 trials, aiming to bring U.S. trial timelines closer to those in China and Australia.
Clinical Trial Data
Phase
Phase_1
Outcome Details
FDA launched pilot program for expedited investigational new drug (IND) application process to speed up phase 1 trials
Importance:5/10
Sentiment:
0.60
FDAPhase 1INDClinical trialsRegulatory
Related Companies
Read the original article
Published by FierceBiotech on September 15, 2026 1:42 PM